Except for everolimus which had been reported to decrease the MRP1 expression levels in cisplatin-resistant gastric cancer cells (Ying et al., 2014), the effect of other identified inhibitors on the protein expression levels of the MRP1 transporter remains to be elucidated. The gene discussed is ABCC1; the disease is gastric cancer.